2023
Assessment of Inflammatory Bowel Disease Training Among Gastroenterology Fellows
Al-Bawardy B, Malter L, Ehrlich A, Rieder F, Gaidos J, Proctor D, Windish D. Assessment of Inflammatory Bowel Disease Training Among Gastroenterology Fellows. Inflammatory Bowel Diseases 2023, 29: 1990-1992. PMID: 36810663, PMCID: PMC11491607, DOI: 10.1093/ibd/izad030.Peer-Reviewed Original ResearchOutcomes of immunomodulator and advanced therapies for primary sclerosing cholangitis-associated inflammatory bowel disease
Sayed A, Assis D, Silveira M, Deng Y, Ciarleglio M, Gaidos J, Proctor D, Al-Bawardy B. Outcomes of immunomodulator and advanced therapies for primary sclerosing cholangitis-associated inflammatory bowel disease. European Journal Of Gastroenterology & Hepatology 2023, 35: 270-274. PMID: 36708297, DOI: 10.1097/meg.0000000000002510.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultCholangitisCholangitis, SclerosingFemaleHumansImmunologic FactorsInflammatory Bowel DiseasesMaleMiddle AgedRetrospective StudiesRisk FactorsConceptsPrimary sclerosing cholangitisInflammatory bowel diseasePSC-IBDEndoscopic healingTherapy groupAdvanced therapiesClinical remissionBowel diseaseAcute ascending cholangitisRate of cholangitisSmall bowel involvementThird of patientsAscending cholangitisSclerosing cholangitisAdult patientsBowel involvementSecondary outcomesMedian agePrimary outcomeRetrospective studyHigh riskCholangitisPatientsTherapyLarger study
2022
A Practical Approach to IBD Care in the Pregnant Patient
Sahyoun L, Gaidos J. A Practical Approach to IBD Care in the Pregnant Patient. Current Gastroenterology Reports 2022, 24: 201-209. PMID: 36422770, DOI: 10.1007/s11894-022-00856-3.Peer-Reviewed Original ResearchConceptsInflammatory bowel diseaseManagement of IBDPrior inflammatory bowel diseaseNew IBD therapiesNew biologic agentsPouch-anal anastomosisSimilar success ratesPurpose of ReviewAsIBD careIBD patientsIBD therapyActive diseaseDisease remissionFetal outcomesIBD treatmentPregnant patientsIBD populationPreconception counselingPregnancy outcomesBiologic agentsBowel diseasePeripartum periodMedication safetyPrevious guidelinesPregnancy
2019
The Incidence and Prevalence of Anxiety, Depression, and Post-traumatic Stress Disorder in a National Cohort of US Veterans With Inflammatory Bowel Disease
Thakur ER, Sansgiry S, Kramer JR, Waljee AK, Gaidos JK, Feagins LA, Govani SM, Dindo L, El-Serag HB, Hou JK. The Incidence and Prevalence of Anxiety, Depression, and Post-traumatic Stress Disorder in a National Cohort of US Veterans With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2019, 26: 1423-1428. PMID: 31728520, PMCID: PMC7441098, DOI: 10.1093/ibd/izz280.Peer-Reviewed Original ResearchMeSH KeywordsAgedAnxietyColitis, UlcerativeCrohn DiseaseDepressionFemaleHumansIncidenceInflammatory Bowel DiseasesMaleMiddle AgedPrevalenceStress Disorders, Post-TraumaticUnited StatesVeteransConceptsInflammatory bowel diseasePrevalence of anxietyPosttraumatic stress disorderMental health problemsStress disorderBowel diseaseUS veteransIncidence rateChronicity of IBDHealth problemsAnnual incidence rateStress disorder diagnosisPosttraumatic stress disorder (PTSD) diagnosisPost-traumatic stress disorderPresence of anxietyIBD patientsStudy cohortNational cohortAnnual prevalenceDiagnosis incidenceDirect standardization methodGeneral populationPatientsPrior anxietyPrevalenceRates of Adverse IBD-Related Outcomes for Patients With IBD and Concomitant Prostate Cancer Treated With Radiation Therapy
Feagins LA, Kim J, Chandrakumaran A, Gandle C, Naik KH, Cipher DJ, Hou JK, Yao MD, Gaidos JKJ. Rates of Adverse IBD-Related Outcomes for Patients With IBD and Concomitant Prostate Cancer Treated With Radiation Therapy. Inflammatory Bowel Diseases 2019, 26: 728-733. PMID: 31412114, DOI: 10.1093/ibd/izz175.Peer-Reviewed Original ResearchConceptsInflammatory bowel diseaseFlare of IBDProstate cancerIBD patientsRadiation treatmentCancer diagnosisRadiation therapyRates of IBDInflammatory bowel disease flaresMultiple logistic regression analysisConcomitant prostate cancerVeterans Affairs hospital systemCharlson Comorbidity IndexRetrospective cohort studyRadiation-treated patientsExternal beam radiationBest treatment approachProstate cancer stageLogistic regression analysisProstate cancer diagnosisDisease flareIBD characteristicsComorbidity indexCohort studyBowel disease
2018
Health Maintenance Documentation Improves for Veterans with IBD Using a Template in the Computerized Patient Record System
Valluru N, Kang L, Gaidos JKJ. Health Maintenance Documentation Improves for Veterans with IBD Using a Template in the Computerized Patient Record System. Digestive Diseases And Sciences 2018, 63: 1782-1786. PMID: 29736836, DOI: 10.1007/s10620-018-5093-5.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overDocumentationElectronic Health RecordsFemaleGuideline AdherenceHumansInflammatory Bowel DiseasesMaleMiddle AgedPreventive Health ServicesRetrospective StudiesConceptsPreventive care measuresComputerized patient record systemCare measuresIBD patientsMedication usePreventive carePatient record systemBackgroundInflammatory bowel diseaseImmunosuppressive medication useRetrospective chart reviewRecord systemHPV vaccinationIBD careChart reviewIBD populationBowel diseasePreventable complicationsProvider documentationClinic notesPhysician performance measuresAimThe aimProvider compliancePatientsDemographic dataMcNemar test
2017
Incidence of and Predictors for Early Discontinuation of Biological Therapies in Veteran Patients with Inflammatory Bowel Disease
Feagins LA, Waljee A, Hou JK, Gu P, Kanjo S, Rudrapatna V, Cipher DJ, Govani S, Gaidos J. Incidence of and Predictors for Early Discontinuation of Biological Therapies in Veteran Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2017, 23: 1434-1439. PMID: 28570429, DOI: 10.1097/mib.0000000000001145.Peer-Reviewed Original ResearchConceptsInflammatory bowel diseaseBiological therapyAdverse drug reactionsConcomitant thiopurinesPrimary nonresponseEarly discontinuationBowel diseaseDrug reactionsDiagnosis of IBDBiological agentsFirst biological agentRetrospective cohort studyInitiation of therapyCourse of therapyVA hospital systemIleocolonic diseaseVA cohortCohort studyVeteran patientsMedical recordsRisk factorsCommon reasonPatientsDiscontinuationTherapy
2016
Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients
Alsaleh A, Gaidos JK, Kang L, Kuemmerle JF. Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients. Digestive Diseases And Sciences 2016, 61: 2602-2607. PMID: 27126205, PMCID: PMC4982818, DOI: 10.1007/s10620-016-4171-9.Peer-Reviewed Original ResearchMeSH KeywordsAbdominal AbscessAdolescentAdultAnastomotic LeakChildColitis, UlcerativeCrohn DiseaseDigestive System Surgical ProceduresFemaleGastrointestinal AgentsHumansIleusInflammatory Bowel DiseasesInfliximabIntestinal ObstructionMaleMiddle AgedPostoperative ComplicationsPreoperative CareReoperationRetrospective StudiesRisk FactorsSurgical Wound InfectionTime FactorsVenous ThromboembolismYoung AdultConceptsLast preoperative dosePostoperative complicationsInflammatory bowel diseasePreoperative doseLast doseUlcerative colitisCrohn's diseaseInflammatory bowel disease patientsMethodsRetrospective chart reviewBowel disease patientsResultsNo significant associationIBD patientsPreoperative statusChart reviewPreoperative useBackgroundThe associationBowel diseaseSurgeon typeSurgery typeSteroid useDisease patientsInfliximabComplicationsPatientsDisease typeOvercoming challenges of treating inflammatory bowel disease in pregnancy
Gaidos JK, Kane SV. Overcoming challenges of treating inflammatory bowel disease in pregnancy. Expert Review Of Clinical Immunology 2016, 12: 871-878. PMID: 26981845, DOI: 10.1586/1744666x.2016.1166958.Peer-Reviewed Original ResearchMeSH KeywordsFemaleHealth PersonnelHumansInflammatory Bowel DiseasesPregnancyPregnancy ComplicationsQuality ImprovementRiskConceptsInflammatory bowel diseaseBowel diseasePeak reproductive yearsHealth care providersReproductive yearsCurrent treatmentCare providersPatient questionsBetter outcomesDate evidencePregnancyTherapeutic monitoringOverall managementExpert recommendationsDiseaseMultiple mechanismsPatientsProvidersReviewCareHow to Optimize Colon Cancer Surveillance in Inflammatory Bowel Disease Patients
Gaidos JK, Bickston SJ. How to Optimize Colon Cancer Surveillance in Inflammatory Bowel Disease Patients. Inflammatory Bowel Diseases 2016, 22: 1219-1230. PMID: 26926040, DOI: 10.1097/mib.0000000000000685.Peer-Reviewed Original ResearchMeSH KeywordsColonic NeoplasmsEarly Detection of CancerHumansInflammatory Bowel DiseasesPopulation SurveillanceConceptsInflammatory bowel disease patientsBowel disease patientsColonic Crohn's diseaseColorectal neoplasiaUlcerative colitisDisease patientsCurrent surveillance guidelinesDuration of diseasePrimary sclerosing cholangitisExtent of diseaseOverall high riskColon cancer surveillanceColonic IBDColorectal dysplasiaSclerosing cholangitisSurveillance colonoscopyConcomitant diagnosisCrohn's diseaseSporadic colon cancerChronic inflammationSociety guidelinesSurveillance guidelinesCancer surveillanceRisk factorsFamily history